TI
XGN icon

Trexquant Investment’s Exagen XGN Stock Holding History

Trexquant Investment’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Sell
33,394
-22,215
-40% -$85.9K ﹤0.01% 1703
2025
Q4 		$338K Buy
55,609
+44,504
+401% +$405K ﹤0.01% 1424
2025
Q3 		$122K Buy
+11,105
New +$98.4K ﹤0.01% 1534

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Trexquant Investment's XGN Position: Q1 2026 in Review

Trexquant Investment reduced its Exagen (XGN) stake by 40% in Q1 2026, selling an estimated $85.9K and leaving 33,394 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Trexquant Investment first reported a position in XGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $338K in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Trexquant Investment held 33,394 shares of Exagen worth $100K as of Q1 2026.
  • Trexquant Investment sold 22,215 Exagen shares in Q1 2026, an estimated $85.9K.
  • Exagen made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1703 holding.
  • Trexquant Investment first reported a position in Exagen in Q3 2025 and has held it in 3 quarters since.
  • Trexquant Investment's Exagen position peaked at $338K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.